Simultaneous chemo and immunotherapy may be better for some with metastatic bladder cancer

(The Mount Sinai Hospital / Mount Sinai School of Medicine) Researchers from Mount Sinai and Sema4, a health information company and Mount Sinai venture, have discovered that giving metastatic bladder cancer patients simultaneous chemotherapy and immunotherapy is safe and that patients whose tumors have certain genetic mutations may respond particularly well to this combination approach, according to the results of a clinical trial published in European Urology.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news